Biofrontera Inc. is a U.S.-based biopharmaceutical company focused on the development, manufacturing, and commercialization of dermatological products, specifically for photodynamic therapy (PDT). Its key products include Ameluz (a prescription drug) and the RhodoLED and BF-RhodoLED lamp series, used to treat actinic keratosis (AK). The company sells directly to dermatology offices and groups across the United States through its national commercial team.
expected 2026-12-14
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-03-19 | 2025-12-31 | 0001493152-26-011625 | EDGAR | 63K words |
| 2025-03-20 | 2024-12-31 | 0001493152-25-011052 | EDGAR | 69K words |
| 2024-03-15 | 2023-12-31 | 0001493152-24-010133 | EDGAR | 80K words |
| 2023-03-13 | 2022-12-31 | 0001493152-23-007472 | EDGAR | 77K words |
| 2022-04-11 | 2021-12-31 | 0001493152-22-009519 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-13 | 2026-06-30 | 0001493152-26-037834 | EDGAR | 26K words |
| 2025-11-12 | 2025-09-30 | 0001493152-25-021945 | EDGAR | 27K words |
| 2025-08-13 | 2025-06-30 | 0001641172-25-023486 | EDGAR | 26K words |
| 2025-05-15 | 2025-03-31 | 0001641172-25-011031 | EDGAR | 21K words |
| 2024-11-14 | 2024-09-30 | 0001493152-24-045220 | EDGAR | 27K words |
| 2024-08-14 | 2024-06-30 | 0001493152-24-032216 | EDGAR | 28K words |
| 2024-05-15 | 2024-03-31 | 0001493152-24-019878 | EDGAR | 26K words |
| 2023-11-09 | 2023-09-30 | 0001493152-23-040132 | EDGAR | 26K words |
| 2023-08-11 | 2023-06-30 | 0001493152-23-027701 | EDGAR | 25K words |
| 2023-05-12 | 2023-03-31 | 0001493152-23-016636 | EDGAR | 20K words |
| 2022-11-14 | 2022-09-30 | 0001493152-22-031682 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001493152-22-022202 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-09-14 | 0001493152-26-042508 | EDGAR | 1K words |
| 2026-08-13 | 0001493152-26-037610 | EDGAR | 4K words |
| 2026-03-19 | 0001493152-26-011545 | EDGAR | 5K words |
| 2026-03-09 | 0001493152-26-009321 | EDGAR | 1K words |
| 2026-02-26 | 0001493152-26-008136 | EDGAR | 1K words |
| 2026-02-09 | 0001493152-26-005717 | EDGAR | 1K words |
| 2026-01-13 | 0001493152-26-001959 | EDGAR | 1K words |
| 2026-01-07 | 0001493152-26-000823 | EDGAR | 1K words |
| 2025-11-13 | 0001493152-25-022133 | EDGAR | 4K words |
| 2025-11-10 | 0001493152-25-021525 | EDGAR | 1K words |
155 total filings indexed. 128 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001858685 |
| Ticker | BFRI |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.biofrontera-us.com |
| Listed | 2021-10-29 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/BFRI (~200 tokens, structured JSON with cryptographic provenance)